| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $638.8M | $682.1M | $700.8M |
| YoY Revenue Growth % | -6.3% | -2.7% | — |
| Gross Profit | $151.1M | $149.5M | — |
| Gross Margin % | 23.7% | 21.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.1M | $1.3M | $39.5M |
| Operating Margin % | 0.6% | 0.2% | 5.6% |
| Net Income (GAAP) | -$20.1M | -$17.1M | $30.2M |
| EBITDA (Normalized) | $20.3M | $22.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $22.3M | $83.5M | $96.6M |
| Capital Expenditures (CapEx) | $20.2M | $26.1M | — |
| Free Cash Flow (FCF) | $2.1M | $57.4M | $96.6M |
| FCF Margin % | 0.3% | 8.4% | 13.8% |
| Return on Invested Capital (ROIC %) | 0.9% | 0.4% | — |
| Cash & Short-Term Equivalents | $14.4M | $5.2M | — |
| Total Debt (Short + Long Term) | $182.8M | $43.3M | — |
| Total Stockholders' Equity | $174.4M | $236.4M | — |